Cautious on US linked uncertainties, India's pharma industry projected to grow between 7 -9 per cent in FY26: ICRA

Despite regulatory uncertainties and tariffs casting a shadow on pharma exports to the US, its largest export market, the Indian pharmaceutical industry expects to see “moderate growth” of between 7 and 9 per cent in the current financial y
Read more...